282 related articles for article (PubMed ID: 23083542)
1. A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome.
Thakur V; Rankin KN; Hartling L; Mackie AS
Cardiol Young; 2013 Aug; 23(4):568-81. PubMed ID: 23083542
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis Examining the Usefulness of Angiotensin Receptor blockers for the Prevention of Aortic Root Dilation in Patients With the Marfan Syndrome.
Al-Abcha A; Saleh Y; Mujer M; Boumegouas M; Herzallah K; Charles L; Elkhatib L; Abdelkarim O; Kehdi M; Abela GS
Am J Cardiol; 2020 Aug; 128():101-106. PubMed ID: 32650901
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials.
Pitcher A; Spata E; Emberson J; Davies K; Halls H; Holland L; Wilson K; Reith C; Child AH; Clayton T; Dodd M; Flather M; Jin XY; Sandor G; Groenink M; Mulder B; De Backer J; Evangelista A; Forteza A; Teixido-Turà G; Boileau C; Jondeau G; Milleron O; Lacro RV; Sleeper LA; Chiu HH; Wu MH; Neubauer S; Watkins H; Dietz H; Baigent C;
Lancet; 2022 Sep; 400(10355):822-831. PubMed ID: 36049495
[TBL] [Abstract][Full Text] [Related]
4. The effects of losartan versus beta-blockers on cardiovascular protection in marfan syndrome: A systematic review and meta-analysis.
Kang YN; Chi SC; Wu MH; Chiu HH
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):182-190. PubMed ID: 31003918
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.
Gambarin FI; Favalli V; Serio A; Regazzi M; Pasotti M; Klersy C; Dore R; Mannarino S; Viganò M; Odero A; Amato S; Tavazzi L; Arbustini E
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):354-62. PubMed ID: 19430350
[TBL] [Abstract][Full Text] [Related]
6. Drug-based cardiovascular prevention in patients with Marfan Syndrome: a systematic review.
Pavasini R; Sanguettoli F; Deserio MA; Bianchi N; Zanarelli L; Fabbri G; Tonet E; Passarini G; Serenelli M; Campo G
Minerva Cardiol Angiol; 2023 Dec; 71(6):611-621. PubMed ID: 36939732
[TBL] [Abstract][Full Text] [Related]
7. Role of angiotensin receptor blockers for management of aortic root dilation associated with Marfan syndrome.
Loomba RS; Arora RR
Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1257-9. PubMed ID: 21985537
[No Abstract] [Full Text] [Related]
8. Angiotensin Receptor Blockers vs. Beta-Blocker Therapy for Marfan Syndrome: A Systematic Review and Meta-Analysis.
Wang Z; Deng X; Kang X; Hu A
Ann Vasc Surg; 2022 May; 82():347-361. PubMed ID: 34998935
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome.
Yetman AT; Bornemeier RA; McCrindle BW
Am J Cardiol; 2005 May; 95(9):1125-7. PubMed ID: 15842990
[TBL] [Abstract][Full Text] [Related]
10. Recent Clinical Drug Trials Evidence in Marfan Syndrome and Clinical Implications.
Singh MN; Lacro RV
Can J Cardiol; 2016 Jan; 32(1):66-77. PubMed ID: 26724512
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of the effect of angiotensin II receptor blocker versus β-blocker on aortic root growth in paediatric patients with Marfan syndrome.
Mueller GC; Stierle L; Stark V; Steiner K; von Kodolitsch Y; Weil J; Mir TS
Heart; 2014 Feb; 100(3):214-8. PubMed ID: 24270746
[TBL] [Abstract][Full Text] [Related]
12. Medical management of aortic disease in children with Marfan syndrome.
Lindsay ME
Curr Opin Pediatr; 2018 Oct; 30(5):639-644. PubMed ID: 30036202
[TBL] [Abstract][Full Text] [Related]
13. Update on Clinical Trials of Losartan With and Without β-Blockers to Block Aneurysm Growth in Patients With Marfan Syndrome: A Review.
Hofmann Bowman MA; Eagle KA; Milewicz DM
JAMA Cardiol; 2019 Jul; 4(7):702-707. PubMed ID: 31066871
[TBL] [Abstract][Full Text] [Related]
14. Medical treatment of Marfan syndrome: a time for change.
Williams A; Davies S; Stuart AG; Wilson DG; Fraser AG
Heart; 2008 Apr; 94(4):414-21. PubMed ID: 18347371
[TBL] [Abstract][Full Text] [Related]
15. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial.
Ahimastos AA; Aggarwal A; D'Orsa KM; Formosa MF; White AJ; Savarirayan R; Dart AM; Kingwell BA
JAMA; 2007 Oct; 298(13):1539-47. PubMed ID: 17911499
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trials.
Meza N; Pérez-Bracchiglione J; Pérez I; Carvajal C; Ortiz-Muñoz L; Olguín P; Rada G; Madrid E;
Medwave; 2021 Mar; 21(2):e8105. PubMed ID: 33830976
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.
Brooke BS; Habashi JP; Judge DP; Patel N; Loeys B; Dietz HC
N Engl J Med; 2008 Jun; 358(26):2787-95. PubMed ID: 18579813
[TBL] [Abstract][Full Text] [Related]
18. Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.
Chiu HH; Wu MH; Wang JK; Lu CW; Chiu SN; Chen CA; Lin MT; Hu FC
Mayo Clin Proc; 2013 Mar; 88(3):271-6. PubMed ID: 23321647
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Heart Network Trial of Losartan vs. Atenolol in Children and Young Adults with Marfan Syndrome: Impact on Prescription Practices.
Robertson DM; Truong DT; Cox DA; Carmichael HL; Ou Z; Minich LL; Williams RV; Selamet Tierney ES
Pediatr Cardiol; 2023 Mar; 44(3):618-623. PubMed ID: 35902413
[TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
